Sanjay Gajendra sold $71M of ALAB
See Remarks at Astera Labs, Inc.. 740,000 shares at an average of $96.59, traded Nov 7, 2024, filed Nov 12, 2024.
Score components
- +15RoleOfficer
- +25Trade size$71.5M at market
- +5Share of holdings soldSold 11% of holdings
- +15Cluster7 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +34.9%, 3m +1.4%, 6m -3.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001736297-24-000045, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 110b5-1 | -150,032 | $94.76 | $14M | 6,775,513 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 110b5-1 | -76,443 | $95.90 | $7.3M | 6,699,070 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 110b5-1 | -254,160 | $96.88 | $25M | 6,444,910 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 110b5-1 | -72,489 | $98.00 | $7.1M | 6,372,421 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 110b5-1 | -56,874 | $98.75 | $5.6M | 6,315,547 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 110b5-1 | -10,002 | $99.59 | $996k | 6,305,545 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 210b5-1 | -14,520 | $94.76 | $1.4M | 820,480 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 210b5-1 | -7,397 | $95.90 | $709k | 813,083 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 210b5-1 | -24,596 | $96.88 | $2.4M | 788,487 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 210b5-1 | -7,015 | $98.00 | $688k | 781,472 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 210b5-1 | -5,504 | $98.75 | $543k | 775,968 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 210b5-1 | -968 | $99.59 | $96k | 775,000 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 310b5-1 | -14,520 | $94.76 | $1.4M | 820,480 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 310b5-1 | -7,398 | $95.90 | $709k | 813,082 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 310b5-1 | -24,595 | $96.88 | $2.4M | 788,487 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 310b5-1 | -7,015 | $98.00 | $688k | 781,472 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 310b5-1 | -5,504 | $98.75 | $543k | 775,968 | Nov 12, 2024 |
| Nov 7, 2024 | SOpen-market sale Common Stockindirect: By Trust 310b5-1 | -968 | $99.59 | $96k | 775,000 | Nov 12, 2024 |
Related signals
Other insiders at Astera Labs, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $4.7M 12,499 shares | -25% | |
| 33Weak | Astera Labs, Inc. | Manuel Alba director | $51M 183,000 shares | -14% | |
| 33Weak | Astera Labs, Inc. | Stefan A Dyckerhoff director | $3.4M 12,499 shares | -23% | |
| 35Weak | Astera Labs, Inc. | Manuel Alba director | $32M 183,000 shares | -10% | |
| 35Weak | Astera Labs, Inc. | Philip Mazzara General Counsel and Secretary | $1.9M 10,000 shares | -6% | |
| 40Moderate | Astera Labs, Inc. | Jack R Lazar director | $4.0M 22,500 shares | -19% | |
| 62Notable | Astera Labs, Inc. | Michael Truett Tate Chief Financial Officer | $3.5M 18,861 shares | -7% | |
| 65Notable | Astera Labs, Inc. | Jitendra Mohan Chief Executive Officer | $17M 91,441 shares | -4% | |
| 55Moderate | Astera Labs, Inc. | Philip Mazzara General Counsel and Secretary | $1.3M 7,237 shares | -4% | |
| 60Notable | Astera Labs, Inc. | Sanjay Gajendra President and COO | $17M 91,441 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.